Scientists at Michigan Medicine have made a significant breakthrough in treating nonalcoholic fatty liver disease (NAFLD), a ...

One of these is non-alcoholic steatohepatitis, or NASH, the fatty liver disease that affects millions of people and which is poised to be one of pharma’s next big growth areas. Novartis ramped ...

In the medical field, terminology not only guides clinical understanding and patient communication but also impacts research, ...

Fatty liver disease can be caused by drinking too ... Fatty buildup in your liver can cause nonalcoholic steatohepatitis and lead to cirrhosis. NASH is linked to high cholesterol, coronary artery ...

That was until my doctors stunned me with the news that I had cirrhosis caused by non-alcoholic steatohepatitis, or NASH, a severe form of fatty liver disease that often has few or no symptoms ...

Previous reviews [19,75–77] have documented that hepatic histology improves in most obese patients with NAFLD and NASH who ... the rare progression of liver disease is the rate of weight loss ...

A study from Massachusetts General Hospital has found that growth hormone may help improve liver health in people with ...

Elevated fat levels in your liver can raise your chances of developing serious health issues, including diabetes, ...

Formerly known as nonalcoholic steatohepatitis (NASH), MASH describes a type ... Unlike some other types of fatty liver disease, MASH does not relate to alcohol use. However, promptly treating ...

Since symptoms don’t appear until the condition worsens, the only way to detect fatty liver early is through blood tests (LFT ...